(Q43027768)

12 November 2017

title

In vitro antituberculosis activities of the constituents isolated from Haloxylon salicornicum (English)

1 reference

12 November 2017

main subject

Haloxylon salicornicum

1 reference

(6aR,8aR,12S,14bS)-4,6a,8a,11,12,14b-hexamethyl-2,3,4,4a,5,6,6b,7,8,9,10,11,12,12a,14,14a-hexadecahydro-1H-picene

1 reference

20-cyclohexylicosan-1-ol

1 reference

5a,8a-Epidioxyergosta-6,9(11),22-trien-3

1 reference

[(3S,4aR,6aR,6bS,8aR,12aR,14aS,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl] hexadecanoate

1 reference

22-cyclohexyldocosan-1-ol

1 reference

(22E,24S)-5alpha,8alpha-epidioxy-24-methylcholesta-6,9,22-trien-3beta-ol

1 reference

22-hydroxy-1-[(3R)-3-hydroxypiperidin-1-yl]docosa-2,4-dien-1-one

1 reference

(3R,4S,5S,6R)-2-[[(8S,9S,10R,13R,14R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-8,10,13-trimethyl-1,2,3,6,7,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

1 reference

(22E,24S)-5alpha,8alpha-epidioxy-24-methylcholesta-6,22-dien-3beta-ol

1 reference

1 reference

(4R,4aS,6aR,6bS,8aR,11R,12S,12aR,14aR,14bS)-4,6a,6b,8a,11,12,14b-heptamethyl-1,2,3,4,4a,5,6,7,8,9,10,11,12,12a,14,14a-hexadecahydropicene

1 reference

1 reference

1 reference

(2R,3R,4R,5R,6S)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-methyloxane-3,4,5-triol

1 reference

[(3S,4aR,6aR,6bS,8aR,12aS,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl] hexadecanoate

1 reference

(2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

stigmasterol 3-O-beta-D-glucoside

1 reference

14-Methyl-15-(1-methylundecyl)-3,4,6,7,8,9,11,12,13,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol

1 reference

[(3S,4aR,6aR,6bS,8aR,12aR,14aR,14bR)-4,4,4a,6a,6b,8a,11,11,12a,14b-decamethyl-1,2,3,5,6,7,8,9,10,12,14,14a-dodecahydropicen-3-yl] hexadecanoate

1 reference

1 reference

1 reference

(2Z,4Z)-22-hydroxy-1-[(3S)-3-hydroxypiperidin-1-yl]docosa-2,4-dien-1-one

1 reference

6-hydroxy-7,8-dimethoxychromen-2-one

1 reference

1 reference

24-Hydroxyoctacosan-4-one

1 reference

1 reference

1 reference

ergosterol endoperoxide

1 reference

(4S,4aS,6aR,6bS,8aR,11R,12S,12aR,14aR,14bS)-4,6a,6b,8a,11,12,14b-heptamethyl-1,2,3,4,4a,5,6,7,8,9,10,11,12,12a,14,14a-hexadecahydropicene

1 reference

(24S)-24-hydroxyoctacosan-4-one

1 reference

22-hydroxy-1-(piperidin-1-yl)docosa-2,4-dien-1-one

1 reference

24-cyclohexyltetracosan-1-ol

1 reference

1 reference

1 reference

Nazia Bibi

1 reference

12 November 2017

Sheraz Ahmad K Tanoli

1 reference

12 November 2017

Sadia Farheen

1 reference

12 November 2017

Nighat Afza

1 reference

12 November 2017

Salman Siddiqi

1 reference

12 November 2017

Ying Zhang

1 reference

12 November 2017

Shahana U Kazmi

1 reference

12 November 2017

Abdul Malik

1 reference

Bioorganic & Medicinal Chemistry Letters

12 November 2017

language of work or name

English

0 references

publication date

July 2010

1 reference

16 September 2022

1 reference

inferred from page(s)

published in

1 reference

12 November 2017

1 reference

12 November 2017

1 reference

12 November 2017

page(s)

4173-4176

1 reference

Haloxylines A and B, antifungal and cholinesterase inhibiting piperidine alkaloids from Haloxylon salicornicum

12 November 2017

cites work

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.53.570

Identifiers

DOI

10.1016/J.BMCL.2010.05.061

1 reference

12 November 2017

1 reference